Table of contents
Occupational liver disease
The following summarized guidelines for the evaluation and management of occupational liver disease are prepared by our editorial team based on guidelines from the European Association for the Study of the Liver (EASL 2020).
1.Screening and diagnosis
Indications for screening: consider ultrasound surveillance for the development of liver neoplasms in workers exposed to high levels of vinyl chloride monomer in the past, that is until the mid-1970s, as defined by their job title (reactor cleaners).
More topics in this section
Screening for fatty liver
2.Classification and risk stratification
Consider the adapted severity index scale designed for DILI for the evaluation of severity of acute chemical liver injury.
Consider dynamic evaluation, including repeated liver tests and liver stiffness measurements by transient elastography or serum predictors of fibrosis such as Fib-4 and APRI, for staging of occupational liver disease after the patient is removed from occupational exposure to suspected toxins.
Consider liver biopsy in patients with persistently abnormal noninvasive liver tests, depending on the clinical context and the extent of the liver abnormalities.
Consider sampling of the non-tumoral liver when performing a liver biopsy to diagnose a liver mass.
Patient awareness: inform workers with potential exposure to hepatotoxic chemicals that they should receive a document listing the chemicals used in the factory. Inform that this document may be made available to the workers without request.
Show 2 more
Public health reporting: inform the relevant health authorities and/or compensation agencies about a documented or suspected case of occupational liver disease.